Furuta, Saori |
Case Western Reserve University
United States |
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer |
5R01CA248304-05 |
|
NINA, BHARDWAJ, |
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
United States |
Immune determinants modulating cancer development in Lynch Syndrome |
1UG3CA290517-01 |
|
Dashwood, Roderick H |
Texas A&M University Health Science Ctr
United States |
Immunoepigenetic targeting of MHC regulators in FAP |
5R01CA257559-03 |
|
Mcguire, Andrew |
Fred Hutchinson Cancer Center
United States |
Rational Vaccine Design to prevent HIV-Associated Lymphoma |
5R01CA285227-02 |
|
Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States |
5U01CA230694-05 |
|
Nath, Kavindra |
University Of Pennsylvania
United States |
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition |
5R01CA228457-05 |
|
Lee, Hakho |
Massachusetts General Hospital
United States |
Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array |
5U01CA284982-02 |
|
Hall, Daniel Lee |
Massachusetts General Hospital
United States |
Innovating CBT-I for Cancer Survivors: An Optimization Trial |
5R21CA279248-02 |
|
Clapper, Margie L. |
Research Inst Of Fox Chase Can Ctr
United States |
Novel small molecule agents to correct pathogenic VHL missense mutations |
3U54CA272686-03S1 |
RFA-CA-21-038 (U54 Clinical Trial Not Allowed) |
Papadopoulos, Nickolas |
Johns Hopkins University
United States |
Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids |
5U01CA230691-07 |
|